Sustainability Report

Overview

The report covers FY22 for Glenmark Pharmaceuticals Limited and its wholly-owned subsidiaries, with environmental data focused on India. It reports 14,967 tCO2e of Scope 1 emissions, 66,739 tCO2e of Scope 2 emissions and 1,19,426 tCO2e of Scope 3 emissions, while committing to carbon neutrality for Scope 1 and Scope 2 by 2030. Social highlights include 13,762 employees, 27% women on the Board, zero fatalities in FY22 and more than 2.6 million lives impacted through CSR programs.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: 1 April 2021 – 31 March 2022
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
SBTi status

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services